Researchers from the Barbara Davis Center for Diabetes at the University of Colorado Anschutz Medical Campus have found that immune responses to insulin could help identify individuals most at risk for developing Type 1 diabetes.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045